
Andromeda Surgical
Andromeda Surgical is a YC Summer 2023 (S23) company. Based in San Francisco, CA, USA. Team of 10.
About Andromeda Surgical
Summary
Andromeda Surgical builds an AI-guided surgical platform that gives surgeons spatial navigation and autonomous task assistance during procedures, starting with endourology. Current surgical robots handle only the physical execution; Andromeda adds a cognitive layer, guiding surgeons through anatomy and automating discrete surgical tasks using models trained on prior case data. The platform targets the operating room as an open, continuously updated system compatible with existing surgical tools.
Go-to-market
Surgeons and hospital systems are the end customers, with the initial commercial focus on prostate enucleation procedures before expanding to other interventional specialties.
From the Y Combinator listing
Autonomous surgical robots
We're building autonomous robots to make surgery safe, easier and more efficient. Robots currently perform about 1/4 of surgeries but only help with the physical aspects. We use AI to make surgery cognitively easier. This has far greater potential to improve outcomes and reduce costs. Founded by 3x founders from medtech and autonomous vehicles, we're on track to be the fastest surgical robot to market of all time. First indication is prostate enucleation.
Facts
- Healthcare / Healthcare -> Medical Devices
- San Francisco, CA, USA
- 10
- Active
- Early
Founders (2)
- Kartik Tiwari
Score every batch against your own thesis
GPAgent's sourcing agent reads every company in a batch, scores each one against your fund's thesis in a private workspace, and lines up the founders worth meeting before Demo Day. You decide who to contact. Your scores, notes, and pipeline never appear on these pages.
How Accelerator intelligence works